<p>A) HaCaT keratinocytes that had been serum-starved overnight were stimulated with FGF7, FGF10 or FGF22 (100 ng/ml) for 0, 15, 30 or 60 minutes and lysed in sample buffer prior to Western blotting. FGF7 and FGF10 elicited rapid ERK phosphorylation, whereas FGF22 yielded no significant response (phospho-ERK staining appears stronger due to increased length of exposure – to allow visualization of bands). B and C) Serum-starved HaCaT cells were stimulated as above with 100 ng/ml FGF7 (B) or FGF10 (C) either following a 4 h pre-treatment with FGF22 (100 ng/ml) or concomitant with FGF22 treatment. In each case, experiments were repeated (n = 5) and bands quantified using ImageJ (bars represent SEM). No reduction in ERK signalling was observed ...
<p>(<b>A</b>) Phosphorylation of FGF-downstream targets Akt and ERK was analyzed in siRNA treated (s...
<p>A) Quantitative RT-PCR of FGFR2 isoforms (FGFR2a, FGFR2b and FGFR2c) in control and heterozygous ...
<p>Western blotting analysis of AKT and ERK1/2 activation (p-AKT; p-ERK1/2). MT1-MMP-expressing Tet-...
<p>For AKT and ERK1/2 phosphorylation, cells were treated with FGF-2 (10 ng/ml) and harvested at (2,...
<p>(A) qRT-PCR analysis showing reduced or absent <i>Erk2</i> transcript in the mutated lines, with ...
<p><i>A and B</i>, Starved MCF10A cells were stimulated with 5 ng/ml TGF-β1 and 50 ng/ml FGF1 in the...
<p>A. In SR H2170 cells, HGF induced pronounced p-ERK signaling compared to parental cells. Cells we...
<p>Cells were treated with varying concentrations of EGF (0.1, 1, 10 ng/ml). Panel A shows fold chan...
<p>(A–B) MDA-MB-231 cells transfected with non-targeting (NT) siRNA or FAK siRNA were immunostained ...
<p>(A) Time-course of EGF stimulation on FAK gene transcription activation in B16F1 cells. The B16F1...
<p>MA-10 cells were treated without or with FGF9 (50 ng/ml) for the indicated times. The expression ...
<p>(<b>A</b>) Fold change in expression levels of two smad regulated genes, PAI-1 and smad7, relativ...
<p>Cells were pre-cultured in DC-FBS for 48 h and then treated with A) 25 ng/ml FGF-8b, B) 10 ng/ml ...
<p>Condition medium of untreated HaCaT cells (-/UN, white bars) was used to treat serum deprived hGF...
<p>A. Stable αPIX<sup>WT</sup> and control (CAT) CHO cell lines were transiently transfected with EG...
<p>(<b>A</b>) Phosphorylation of FGF-downstream targets Akt and ERK was analyzed in siRNA treated (s...
<p>A) Quantitative RT-PCR of FGFR2 isoforms (FGFR2a, FGFR2b and FGFR2c) in control and heterozygous ...
<p>Western blotting analysis of AKT and ERK1/2 activation (p-AKT; p-ERK1/2). MT1-MMP-expressing Tet-...
<p>For AKT and ERK1/2 phosphorylation, cells were treated with FGF-2 (10 ng/ml) and harvested at (2,...
<p>(A) qRT-PCR analysis showing reduced or absent <i>Erk2</i> transcript in the mutated lines, with ...
<p><i>A and B</i>, Starved MCF10A cells were stimulated with 5 ng/ml TGF-β1 and 50 ng/ml FGF1 in the...
<p>A. In SR H2170 cells, HGF induced pronounced p-ERK signaling compared to parental cells. Cells we...
<p>Cells were treated with varying concentrations of EGF (0.1, 1, 10 ng/ml). Panel A shows fold chan...
<p>(A–B) MDA-MB-231 cells transfected with non-targeting (NT) siRNA or FAK siRNA were immunostained ...
<p>(A) Time-course of EGF stimulation on FAK gene transcription activation in B16F1 cells. The B16F1...
<p>MA-10 cells were treated without or with FGF9 (50 ng/ml) for the indicated times. The expression ...
<p>(<b>A</b>) Fold change in expression levels of two smad regulated genes, PAI-1 and smad7, relativ...
<p>Cells were pre-cultured in DC-FBS for 48 h and then treated with A) 25 ng/ml FGF-8b, B) 10 ng/ml ...
<p>Condition medium of untreated HaCaT cells (-/UN, white bars) was used to treat serum deprived hGF...
<p>A. Stable αPIX<sup>WT</sup> and control (CAT) CHO cell lines were transiently transfected with EG...
<p>(<b>A</b>) Phosphorylation of FGF-downstream targets Akt and ERK was analyzed in siRNA treated (s...
<p>A) Quantitative RT-PCR of FGFR2 isoforms (FGFR2a, FGFR2b and FGFR2c) in control and heterozygous ...
<p>Western blotting analysis of AKT and ERK1/2 activation (p-AKT; p-ERK1/2). MT1-MMP-expressing Tet-...